BRIEF published on 04/16/2024 at 18:10, 7 months 4 days ago Galenica Successfully Issues CHF 100 Million Bond Corporate Finance SIX Swiss Exchange Bond Issue Financial Stability Galenica AG
PRESS RELEASE published on 04/16/2024 at 18:05, 7 months 4 days ago Galenica successfully places a bond of over CHF 100 million Galenica successfully places a CHF 100 million fixed rate bond with a 7-year term and 1.65% annual coupon. The proceeds will be used for general corporate purposes, securing long-term financing Bond Long-term Financing Galenica AG CHF 100 Million Fixed Rate
BRIEF published on 04/10/2024 at 17:34, 7 months 10 days ago Shareholders of Galenica AG unanimously approve at the 7th Ordinary General Meeting Board Of Directors Dividend Annual Accounts General Assembly Galenica SA
PRESS RELEASE published on 04/10/2024 at 17:29, 7 months 10 days ago 7th Annual General Meeting: Shareholders approve all proposals Galenica Ltd.'s 7th Annual General Meeting sees approval of all proposals, including dividend of CHF 2.20 per share and re-election of Board of Directors members Board Of Directors Annual General Meeting Dividend Approval Galenica Ltd.
BRIEF published on 03/12/2024 at 06:50, 8 months 9 days ago Galenica announces sustained growth in 2023 and optimistic forecasts for 2024 Financial Results Sustainable Development Online Pharmacy Galenica Growth 2024
PRESS RELEASE published on 03/12/2024 at 06:45, 8 months 9 days ago Galenica continues to grow in the 2023 financial year Galenica Group achieves 4.4% sales growth in 2023, proposing stable dividend. Expects 3-5% sales growth in 2024, increased adjusted EBIT by 8-11% 2024 Outlook Sales Growth Dividend Proposal Galenica Group Adjusted EBIT Increase
Published on 11/21/2024 at 13:00, 37 minutes ago Aclara Secures Funding from Corfo's Innovation High-Tech Program for Artificial Intelligence Project
Published on 11/21/2024 at 13:00, 37 minutes ago Telomir Pharmaceuticals Confirms Age Reversal, Increased Longevity and Improved Healthspan in Groundbreaking Preclinical Study with Telomir-1
Published on 11/21/2024 at 13:00, 37 minutes ago Toggle3D.ai Rebrands as FOTOgpt.ai to Usher in a New Age of AI-Powered Photography
Published on 11/21/2024 at 13:00, 37 minutes ago Nextech3D.ai Spin-Out Rebrands as FOTOgpt.ai to Usher in a New Era of AI-Powered Photography
Published on 11/21/2024 at 13:00, 37 minutes ago Clean Air Metals Announces Positive Results from Innovative Seismic Survey at the Escape Deposit Down-Plunge Extension
Published on 11/21/2024 at 12:35, 1 hour 2 minutes ago audius with successful third quarter 2024 - total revenue grows by +9.2% and EBITDA by +14.6
Published on 11/21/2024 at 12:15, 1 hour 22 minutes ago Hardman & Co Investor Forum Research on Shield Therapeutics (STX): Proactive cash management to cashflow-breakeven
Published on 11/21/2024 at 06:58, 6 hours 39 minutes ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 18 hours 17 minutes ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 19 hours 52 minutes ago MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 19 hours 52 minutes ago Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 5 hours ago Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo
